Conexeu Sciences Statistics
Total Valuation
CNXU has a market cap or net worth of $198.46 million. The enterprise value is $193.63 million.
| Market Cap | 198.46M |
| Enterprise Value | 193.63M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CNXU has 19.85 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 19.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 26.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,218.25 |
Financial Efficiency
Return on equity (ROE) is -53.36% and return on invested capital (ROIC) is -157.10%.
| Return on Equity (ROE) | -53.36% |
| Return on Assets (ROA) | -51.03% |
| Return on Invested Capital (ROIC) | -157.10% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.96M |
| Pretax Income | -3.92M |
| Net Income | -3.92M |
| EBITDA | -3.90M |
| EBIT | -3.92M |
| Earnings Per Share (EPS) | -$0.20 |
Full Income Statement Balance Sheet
The company has $4.83 million in cash and $3,722 in debt, with a net cash position of $4.83 million or $0.24 per share.
| Cash & Cash Equivalents | 4.83M |
| Total Debt | 3,722 |
| Net Cash | 4.83M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 7.35M |
| Book Value Per Share | 0.37 |
| Working Capital | 7.12M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$1.67 million and capital expenditures -$18,668, giving a free cash flow of -$1.69 million.
| Operating Cash Flow | -1.67M |
| Capital Expenditures | -18,668 |
| Free Cash Flow | -1.69M |
| FCF Per Share | -$0.09 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |